| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 11,940 | 12,260 | 08:30 |
| BioLife Solutions, Inc.: BioLife Solutions Reports Second Quarter 2026 Financial Results | Total revenue of $28.5 million, up 21% over Q2 2025
GAAP gross margin of 64% and non-GAAP adjusted gross margin of 65%
GAAP net income of $45.1 million, inclusive... ► Artikel lesen |
| Repligen Corporation: Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media | Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market by adding BioLife's differentiated, high-margin recurring revenue business BioLife... ► Artikel lesen |
| BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2026 Financial Results | Total revenue of $27.5 million, up 25% over Q1 2025
GAAP gross margin and non-GAAP adjusted gross margin of 64%
GAAP net income of $1.2 million and non-GAAP adjusted... ► Artikel lesen |